Tirzepatide (Mounjaro): Novel Solution For The Management Of Type 2 Diabetes And Obesity
- Published: Sep, 2025
- Report ID: GVR-MT-100413
- Format: PDF/Excel databook
- No. of Pages/Datapoints: 150
- Report Coverage: 2024 - 2030
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Indication
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Tirzepatide (Mounjaro) Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
Chapter 4. Tirzepatide (Mounjaro) Market: Indication Business Analysis
4.1. Indication Market Share, 2024 & 2033
4.2. Indication Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Million)
4.4. Type 2 Diabetes Mellitus(IV)
4.4.1. Type 2 Diabetes Mellitus Market, 2021 - 2033 (USD Million)
4.5. Chronic Weight Management
4.5.1. Chronic Weight Management Market, 2021 - 2033 (USD Million)
Chapter 5. Tirzepatide (Mounjaro) Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2024 & 2033
5.2. Regional Market Dashboard
5.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
5.4. North America
5.4.1. North America Daratumumab (DARZALEX) Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
5.5. Europe
5.5.1. Europe Daratumumab (DARZALEX) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific Daratumumab (DARZALEX) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Latin America
5.7.1. Latin America Daratumumab (DARZALEX) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Middle East and Africa
5.8.1. Middle East and Africa Daratumumab (DARZALEX) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Profile
6.1.1. Eli Lilly and Company
6.1.1.1. Overview
6.1.1.2. Financial Performance
6.1.1.3. Strategic Mapping
6.2. Concurrent Competitive Landscape
6.2.1. Novo Nordisk
6.2.1.1. Overview
6.2.1.2. Financial Performance
6.2.1.3. Disease Benchmarking
6.2.1.4. Strategic Mapping
6.2.2. Amgen
6.2.2.1. Overview
6.2.2.2. Financial Performance
6.2.2.3. Disease Benchmarking
6.2.2.4. Strategic Mapping
6.2.3. Roche / Genentech
6.2.3.1. Overview
6.2.3.2. Financial Performance
6.2.3.3. Disease Benchmarking
6.2.3.4. Strategic Mapping
6.2.4. Boehringer Ingelheim
6.2.4.1. Overview
6.2.4.2. Financial Performance
6.2.4.3. Disease Benchmarking
6.2.4.4. Strategic Mapping
6.2.5. Structure Therapeutics
6.2.5.1. Overview
6.2.5.2. Financial Performance
6.2.5.3. Disease Benchmarking
6.2.5.4. Strategic Mapping
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Tirzepatide (Mounjaro) market, by region, 2021 - 2033 (USD Million)
Table 4 Global Tirzepatide (Mounjaro) market, by indication, 2021 - 2033 (USD Million)
Table 5 North America Tirzepatide (Mounjaro) market, by country, 2021 - 2033 (USD Million)
Table 6 North America Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 7 U.S. Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 8 Canada Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 9 Mexico Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 10 Europe Tirzepatide (Mounjaro) market, by country, 2021 - 2033 (USD Million)
Table 11 Europe Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 12 UK Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 13 Germany Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 14 France Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 15 Italy Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 16 Spain Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 17 Norway Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 18 Denmark Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 19 Sweden Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 20 Asia Pacific Tirzepatide (Mounjaro) market, by country, 2021 - 2033 (USD Million)
Table 21 Asia Pacific Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 22 Japan Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 23 China Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 24 India Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 25 Australia Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 26 South Korea Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 27 Thailand Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 28 Latin America Tirzepatide (Mounjaro) market, by country, 2021 - 2033 (USD Million)
Table 29 Latin America Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 30 Brazil Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 31 Argentina Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 32 Middle East & Africa Tirzepatide (Mounjaro) market, by country, 2021 - 2033 (USD Million)
Table 33 Middle East & Africa Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 34 South Africa Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 35 Saudi Arabia Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 36 UAE Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
Table 37 Kuwait Tirzepatide (Mounjaro) market, by Indication, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Tirzepatide (Mounjaro) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Tirzepatide (Mounjaro) market dynamics
Fig. 12 Tirzepatide (Mounjaro) market: Porter’s five forces analysis
Fig. 13 Tirzepatide (Mounjaro) market: PESTLE analysis
Fig. 14 Type 2 Diabetes Mellitus market, 2021 - 2033 (USD Million)
Fig. 15 Chronic Weight Management market, 2021 - 2033 (USD Million)
Fig. 16 Tirzepatide (Mounjaro) market revenue, by region
Fig. 17 Regional marketplace: Key takeaways
Fig. 18 North America Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 19 U.S. country dynamics
Fig. 20 U.S. Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 21 Canada country dynamics
Fig. 22 Canada Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 23 Mexico country dynamics
Fig. 24 Mexico Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 25 Europe Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 26 UK country dynamics
Fig. 27 UK Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 28 Germany country dynamics
Fig. 29 Germany Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 30 France country dynamics
Fig. 31 France Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 32 Italy country dynamics
Fig. 33 Italy Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 34 Spain country dynamics
Fig. 35 Spain Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 36 Norway country dynamics
Fig. 37 Norway Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 38 Sweden country dynamics
Fig. 39 Sweden Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 40 Denmark country dynamics
Fig. 41 Denmark Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 42 Asia Pacific Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 43 Japan country dynamics
Fig. 44 Japan Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 45 China country dynamics
Fig. 46 China Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 47 India country dynamics
Fig. 48 India Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 49 Australia country dynamics
Fig. 50 Australia Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 51 South Korea country dynamics
Fig. 52 South Korea Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 53 Thailand country dynamics
Fig. 54 Thailand Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 55 Latin America Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 56 Brazil country dynamics
Fig. 57 Brazil Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 58 Argentina country dynamics
Fig. 59 Argentina Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 60 MEA Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 61 South Africa country dynamics
Fig. 62 South Africa Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 63 Saudi Arabia country dynamics
Fig. 64 Saudi Arabia Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 65 UAE country dynamics
Fig. 66 UAE Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 67 Kuwait country dynamics
Fig. 68 Kuwait Tirzepatide (Mounjaro) market, 2021 - 2033 (USD Million)
Fig. 69 Company categorization
Fig. 70 Company market position analysis
Fig. 71 Strategic framework
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.